Reducing inappropriate testing in the diagnosis of the menopause and peri-menopause

Post Reprod Health. 2016 Sep;22(3):131-2. doi: 10.1177/2053369116634960. Epub 2016 Mar 7.

Abstract

The menopause should be diagnosed based on age, menstrual history and clinical symptoms, and as such, follicle stimulating hormone testing may be considered inappropriate when diagnosing the menopause or peri-menopause in women aged 45 and over. As part of a demand optimisation programme, the number of follicle stimulating hormone tests requested to diagnose the menopause in this age group was quantified and educational interventions were implemented to reduce inappropriate testing. The number of follicle stimulating hormone tests requested to diagnose the menopause in women aged 45 and over was successfully and sustainably reduced.

Keywords: Demand optimisation; follicle stimulating hormone; menopause.

MeSH terms

  • Estradiol
  • Female
  • Follicle Stimulating Hormone
  • Humans
  • Luteinizing Hormone
  • Menopause*
  • Middle Aged
  • Perimenopause*
  • Unnecessary Procedures*

Substances

  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone